J Neurol Surg A Cent Eur Neurosurg 2017; 78(04): 374-379
DOI: 10.1055/s-0037-1599055
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Changes in Regulatory T-Cell Levels in Acute Cerebral Ischemia

Xuerui Pang
1   Department of Neurology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, China
Weidong Qian
1   Department of Neurology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, China
› Author Affiliations
Further Information

Publication History

26 July 2016

31 October 2016

Publication Date:
20 March 2017 (online)


Background Acute stroke causes intense and significant changes in the immune system as well as in the number and the ratio of various immune cells.

Material and Methods Several large-scale studies have shown that ischemic stroke leaves the human body in a state of immunodepression. The regulatory T (Treg) cells may be strongly associated with a change of immune status. In this trial, we collected venous blood from a cohort of patients who were diagnosed with acute ischemic stroke within the last 24 hours (n = 139). We obtained their Treg cells/CD4+ T-cell ratio (Treg%) on days 1, 3, 7, and 14 using flow cytometry.

Results We divided the patients into groups A and B based on the cerebral infarct volume being lesser or greater than 28.6 mL (the median infarct volume), respectively (calculated using the Pullicino formula). We also divided them per the trial of ORG 10172 in acute stroke treatment (TOAST) criteria. Compared with the controls, group A patients showed a slight increase on day 1 and an increase on days 3, 7, and 14 (p < 0.05). group B patients showed a decrease on days 1 and 3 and an increase on days 7 and 14 (p < 0.05). Group B patients showed higher infection rates than group A patients. We used repeated analysis of variance to confirm that gender, cerebral hemisphere, and infection had no influence on the frequency of Treg cells.

Conclusion Our findings indicate that the Treg cells/CD4+ T-cell ratios undergo different changes in frequency in small- and large-volume strokes.

  • References

  • 1 Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke 1996; 27 (03) 415-420
  • 2 Grau AJ, Buggle F, Schnitzler P, Spiel M, Lichy C, Hacke W. Fever and infection early after ischemic stroke. J Neurol Sci 1999; 171 (02) 115-120
  • 3 Prass K, Meisel C, Höflich C. , et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198 (05) 725-736
  • 4 Klehmet J, Harms H, Richter M. , et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009; 158 (03) 1184-1193
  • 5 Brea D, Sobrino T, Ramos-Cabrer P, Castillo J. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovasc Dis 2009; 27 (Suppl. 01) 48-64
  • 6 Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006; 26 (05) 654-665
  • 7 An C, Shi Y, Li P. , et al. Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol 2014; 115: 6-24
  • 8 Liesz A, Hagmann S, Zschoche C. , et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 2009; 40 (08) 2849-2858
  • 9 Gelderblom M, Leypoldt F, Steinbach K. , et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40 (05) 1849-1857
  • 10 Schroeter M, Jander S. T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Med 2005; 7 (03) 183-195
  • 11 del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000; 10 (01) 95-112
  • 12 Abbas AK, Benoist C, Bluestone JA. , et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013; 14 (04) 307-308
  • 13 Haribhai D, Williams JB, Jia S. , et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011; 35 (01) 109-122
  • 14 Hoeppli RE, Wu D, Cook L, Levings MK. The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome. Front Immunol 2015; 6: 61
  • 15 Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10 (07) 490-500
  • 16 Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol 2013; 14 (10) 1007-1013
  • 17 Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133 (05) 775-787
  • 18 Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11 (01) 7-13
  • 19 Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H. The plasticity and stability of regulatory T cells. Nat Rev Immunol 2013; 13 (06) 461-467
  • 20 O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10 (08) 801-805
  • 21 Campbell DJ. Control of regulatory T cell migration, function, and homeostasis. J Immunol 2015; 195 (06) 2507-2513
  • 22 Liesz A, Suri-Payer E, Veltkamp C. , et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009; 15 (02) 192-199
  • 23 Li P, Mao L, Zhou G. , et al. Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia. Stroke 2013; 44 (12) 3509-3515
  • 24 Na SY, Mracsko E, Liesz A, Hünig T, Veltkamp R. Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice. Stroke 2015; 46 (01) 212-220
  • 25 Kleinschnitz C, Kraft P, Dreykluft A. , et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013; 121 (04) 679-691
  • 26 Saxena A, Dobaczewski M, Rai V. , et al. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol 2014; 307 (08) H1233-H1242
  • 27 Vogelgesang A, Grunwald U, Langner S. , et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008; 39 (01) 237-241
  • 28 Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6 (10) 775-786
  • 29 Hug A, Liesz A, Muerle B. , et al. Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke 2011; 42 (12) 3580-3586
  • 30 Yan J, Read SJ, Henderson RD. , et al. Frequency and function of regulatory T cells after ischaemic stroke in humans. J Neuroimmunol 2012; 243 (1-2): 89-94
  • 31 Koch HJ, Uyanik G, Bogdahn U, Ickenstein GW. Relation between laterality and immune response after acute cerebral ischemia. Neuroimmunomodulation 2006; 13 (01) 8-12
  • 32 Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008; 9 (03) 239-244
  • 33 Stubbe T, Ebner F, Richter D. , et al. Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. J Cereb Blood Flow Metab 2013; 33 (01) 159
  • 34 Liu Y, Cheng LS, Wu SD. , et al. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection. Clin Sci (Lond) 2016; 130 (11) 907-919
  • 35 Betts RJ, Prabhu N, Ho AW. , et al. Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response. J Virol 2012; 86 (05) 2817-2825
  • 36 Shafiani S, Dinh C, Ertelt JM. , et al. Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity 2013; 38 (06) 1261-1270
  • 37 Richert-Spuhler LE, Lund JM. The immune fulcrum: regulatory T cells tip the balance between pro- and anti-inflammatory outcomes upon infection. Prog Mol Biol Transl Sci 2015; 136: 217-243
  • 38 Hug A, Dalpke A, Wieczorek N. , et al. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 2009; 40 (10) 3226-3232
  • 39 Wang J, Yu L, Jiang C. , et al. Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun 2015; 43: 172-183
  • 40 Denes A, McColl BW, Leow-Dyke SF. , et al. Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J Cereb Blood Flow Metab 2011; 31 (04) 1036-1050
  • 41 Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol 2012; 8 (07) 401-410
  • 42 Engelhardt B. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J Neurol Sci 2008; 274 (1–2): 23-26
  • 43 Schneider-Hohendorf T, Stenner MP, Weidenfeller C. , et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur J Immunol 2010; 40 (12) 3581-3590
  • 44 Joo SP, Xie W, Xiong X, Xu B, Zhao H. Ischemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in mice. Neuroscience 2013; 243: 149-157
  • 45 Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007; 38 (03) 1097-1103
  • 46 Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009; 158 (03) 1098-1111
  • 47 Offner H, Subramanian S, Parker SM. , et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 2006; 176 (11) 6523-6531
  • 48 Liesz A, Dalpke A, Mracsko E. , et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci 2015; 35 (02) 583-598